Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments

被引：52

作者：

Xu, Xiaoming ^{[1
]}

Al-Ghabeish, Manar ^{[1
]}

Rahman, Ziyaur ^{[1
]}

Krishnaiah, Yellela S. R. ^{[1
]}

Yerlikaya, Firat ^{[1
]}

Yang, Yang ^{[1
]}

Manda, Prashanth ^{[1
]}

Hunt, Robert L. ^{[1
]}

Khan, Mansoor A. ^{[1
]}

机构：

[1] US FDA, CDER, OPQ, OTR,DPQR, Silver Spring, MD 20993 USA

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2015年 / 493卷 / 1-2期

关键词：

Ophthalmic ointments; Acyclovir; In vitro release testing; Corneal drug permeation; Rheology; Yield stress; Equivalence evaluation; Multivariate analysis; Design of experiments (DoE);

D O I：

10.1016/j.ijpharm.2015.07.066

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Owing to its unique anatomical and physiological functions, ocular surface presents special challenges for both design and performance evaluation of the ophthalmic ointment drug products formulated with a variety of bases. The current investigation was carried out to understand and identify the appropriate in vitro methods suitable for quality and performance evaluation of ophthalmic ointment, and to study the effect of formulation and process variables on its critical quality attributes (CQA). The evaluated critical formulation variables include API initial size, drug percentage, and mineral oil percentage while the critical process parameters include mixing rate, temperature, time and cooling rate. The investigated quality and performance attributes include drug assay, content uniformity, API particle size in ointment, rheological characteristics, in vitro drug release and in vitro transcorneal drug permeation. Using design of experiments (DoE) as well as a novel principle component analysis approach, five of the quality and performance attributes (API particle size, storage modulus of ointment, high shear viscosity of ointment, in vitro drug release constant and in vitro transcorneal drug permeation rate constant) were found to be highly influenced by the formulation, in particular the strength of API, and to a lesser degree by processing variables. Correlating the ocular physiology with the physicochemical characteristics of acyclovir ophthalmic ointment suggested that in vitro quality metrics could be a valuable predictor of its in vivo performance. Published by Elsevier B.V.

引用

页码：412 / 425

页数：14

共 51 条

[1]

Title 21: Food and Drugs: Part 320 - Bioavailability and Bioequivalence Requirements, Subpart A - General Provisions, (2015)

[2]

Title 21: Food and Drugs: Part 320 - Bioavailability and Bioequivalence Requirements, Subpart B - Procedures for Determining the Bioavailability or Bioequivalence of Drug Products, (2015)

[3]

Acosta E.P., Flexner C., Chapter 58: Antiviral agents (nonretroviral), Goodman & Gilman's the Pharmacological Basis of Therapeutics. Twelfth Ed., (2011)

[4]

Anand B., Mitra A., Mechanism of corneal permeation of l-valyl ester of acyclovir: Targeting the oligopeptide transporter on the rabbit cornea, Pharm. Res., 19, pp. 1194-1202, (2002)

[5]

Bhandari M., Lochner H., Tornetta P., Effect of continuous versus dichotomous outcome variables on study power when sample sizes of orthopaedic randomized trials are small, Arch. Orthop. Trauma Surg., 122, pp. 96-98, (2002)

[6]

Bron A.J., Tiffany J.M., Gouveia S.M., Yokoi N., Voon L.W., Functional aspects of the tear film lipid layer, Exp. Eye Res., 78, pp. 347-360, (2004)

[7]

Bron A.J., Yokoi N., Gaffney E.A., Tiffany J.M., A solute gradient in the tear meniscus. I. A hypothesis to explain Marx's line, Ocul. Surf., 9, pp. 70-91, (2011)

[8]

Dailymed, Product Label: Zovirax (Acyclovir Ointment 5%), (2015)

[9]

Doane M.G., Interactions of eyelids and tears in corneal wetting and the dynamics of the normal human eyeblink, Am. J. Ophthalmol., 89, pp. 507-516, (1980)

[10]

Donner A., Eliasziw M., Statistical implications of the choice between a dichotomous or continuous trait in studies of interobserver agreement, Biometrics, 50, pp. 550-555, (1994)

← 1 2 3 4 5 6 →